Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Current and potential inflammation targeted therapies in head and neck cancer Wang F; Arun P; Friedman J; Chen Z; Van Waes CCurr Opin Pharmacol 2009[Aug]; 9 (4): 389-95Inflammation often exists in the tumor microenvironment and is induced by inflammatory mediators (cytokines, chemokines, and growth factors) produced by the tumor, stroma, and infiltrating cells. These factors modulate tissue remodeling and angiogenesis and actively promote tumor cell survival and chemoresistance through autocrine and paracrine mechanisms. Head and neck squamous cell carcinomas (HNSCCs) are highly inflammatory and aggressive in nature, and they express a number of cytokines and growth factors involved in inflammation. These cytokines and growth factors activate important signal transduction pathways, including NF-kappaB, JAK/STAT, and PI3K/Akt/mTOR, which regulate the expression of genes controlling growth, survival, and chemosensitivity. This review provides an update on recent advances in the understanding of the mechanisms driving cancer-related inflammation in HNSCC and on molecular targeted therapies under preclinical and clinical investigation.|Angiogenesis Inhibitors/administration & dosage[MESH]|Animals[MESH]|Anti-Inflammatory Agents/administration & dosage/therapeutic use[MESH]|Antineoplastic Agents/administration & dosage/therapeutic use[MESH]|Drug Delivery Systems/*methods[MESH]|Gene Targeting/methods[MESH]|Genetic Therapy/methods[MESH]|Head and Neck Neoplasms/drug therapy/genetics/*metabolism[MESH]|Humans[MESH]|Inflammation Mediators/antagonists & inhibitors/*physiology[MESH]|Inflammation/genetics/metabolism/*pathology/therapy[MESH]|Signal Transduction/physiology[MESH] |